Zimmer Biomet Holdings Shares Outstanding 2010-2025 | ZBH
Zimmer Biomet Holdings shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Zimmer Biomet Holdings shares outstanding for the quarter ending March 31, 2025 were 0.200B, a 3.15% decline year-over-year.
- Zimmer Biomet Holdings 2024 shares outstanding were 0.204B, a 2.77% decline from 2023.
- Zimmer Biomet Holdings 2023 shares outstanding were 0.21B, a 0.29% decline from 2022.
- Zimmer Biomet Holdings 2022 shares outstanding were 0.21B, a 0.05% decline from 2021.
| Zimmer Biomet Holdings Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 204 |
| 2023 | 210 |
| 2022 | 210 |
| 2021 | 210 |
| 2020 | 207 |
| 2019 | 207 |
| 2018 | 204 |
| 2017 | 204 |
| 2016 | 202 |
| 2015 | 190 |
| 2014 | 172 |
| 2013 | 172 |
| 2012 | 176 |
| 2011 | 189 |
| 2010 | 201 |
| 2009 | 216 |
| Zimmer Biomet Holdings Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 200 |
| 2024-12-31 | 204 |
| 2024-09-30 | 203 |
| 2024-06-30 | 206 |
| 2024-03-31 | 206 |
| 2023-12-31 | 210 |
| 2023-09-30 | 210 |
| 2023-06-30 | 210 |
| 2023-03-31 | 210 |
| 2022-12-31 | 210 |
| 2022-09-30 | 210 |
| 2022-06-30 | 210 |
| 2022-03-31 | 210 |
| 2021-12-31 | 210 |
| 2021-09-30 | 211 |
| 2021-06-30 | 211 |
| 2021-03-31 | 210 |
| 2020-12-31 | 207 |
| 2020-09-30 | 209 |
| 2020-06-30 | 207 |
| 2020-03-31 | 207 |
| 2019-12-31 | 207 |
| 2019-09-30 | 207 |
| 2019-06-30 | 206 |
| 2019-03-31 | 206 |
| 2018-12-31 | 204 |
| 2018-09-30 | 205 |
| 2018-06-30 | 205 |
| 2018-03-31 | 205 |
| 2017-12-31 | 204 |
| 2017-09-30 | 204 |
| 2017-06-30 | 204 |
| 2017-03-31 | 203 |
| 2016-12-31 | 202 |
| 2016-09-30 | 203 |
| 2016-06-30 | 199 |
| 2016-03-31 | 202 |
| 2015-12-31 | 190 |
| 2015-09-30 | 206 |
| 2015-06-30 | 173 |
| 2015-03-31 | 173 |
| 2014-12-31 | 172 |
| 2014-09-30 | 172 |
| 2014-06-30 | 171 |
| 2014-03-31 | 172 |
| 2013-12-31 | 172 |
| 2013-09-30 | 172 |
| 2013-06-30 | 171 |
| 2013-03-31 | 171 |
| 2012-12-31 | 176 |
| 2012-09-30 | 175 |
| 2012-06-30 | 176 |
| 2012-03-31 | 179 |
| 2011-12-31 | 189 |
| 2011-09-30 | 189 |
| 2011-06-30 | 193 |
| 2011-03-31 | 194 |
| 2010-12-31 | 201 |
| 2010-09-30 | 200 |
| 2010-06-30 | 203 |
| 2010-03-31 | 204 |
| 2009-12-31 | 216 |
| 2009-09-30 | 215 |
| 2009-06-30 | 216 |
| 2009-03-31 | 222 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.277B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $151.037B | 37.81 |
| Stryker (SYK) | United States | $146.527B | 30.64 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $112.146B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.313B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.826B | 28.39 |
| ResMed (RMD) | United States | $36.979B | 27.77 |
| Agilent Technologies (A) | United States | $32.895B | 21.44 |
| GE HealthCare Technologies (GEHC) | United States | $32.794B | 15.57 |
| Terumo (TRUMY) | Japan | $26.561B | 34.50 |
| Koninklijke Philips (PHG) | Netherlands | $22.051B | 15.85 |
| Insulet (PODD) | United States | $21.941B | 86.12 |
| Baxter (BAX) | United States | $15.529B | 11.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.253B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.430B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.971B | 20.78 |
| Lantheus Holdings (LNTH) | United States | $5.642B | 14.23 |
| Prestige Consumer Healthcare (PBH) | United States | $4.203B | 18.78 |
| Perrigo (PRGO) | Ireland | $3.596B | 9.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.385B | 15.42 |
| ICU Medical (ICUI) | United States | $3.275B | 24.15 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $1.997B | 13.73 |
| LeMaitre Vascular (LMAT) | United States | $1.901B | 42.49 |
| AtriCure (ATRC) | United States | $1.730B | 0.00 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.201B | 12.19 |
| Neogen (NEOG) | United States | $1.131B | 14.47 |
| BioLife Solutions (BLFS) | United States | $1.126B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.100B | 24.74 |
| Kestra Medical Technologies (KMTS) | United States | $1.063B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.895B | 9.02 |
| Capricor Therapeutics (CAPR) | United States | $0.650B | 0.00 |
| Evolus (EOLS) | United States | $0.647B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Owens & Minor (OMI) | United States | $0.619B | 5.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.584B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Surmodics (SRDX) | United States | $0.420B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.408B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.76 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 57.20 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.87 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Biote (BTMD) | United States | $0.210B | 5.89 |
| Quanterix (QTRX) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.25 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.86 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Jin Medical (ZJYL) | China | $0.120B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.59 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.14 |
| Nephros (NEPH) | United States | $0.036B | 48.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |